Clinical Trials Browser

OTHER_GOV × Colorectal Neoplasms × Immune Checkpoint Inhibitors × Clear all

NCT06321081 2024-03-20

ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRC

Phase 2 Recruiting

Gastrointestinal

Colorectal Neoplasms